Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
W.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.250NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.63NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.130NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.44NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.315NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.204NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.50NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.170NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.232NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.84NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.76NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.301NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.269NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.165NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
V.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.149NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.413NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.107NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.10 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-4360.53China
B.47NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.41 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.71NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AS.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.142NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.166NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.11 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.34.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.234NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Z.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
V.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.282NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.131NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.274NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.235NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.65NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.64NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used